Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 16

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial

Connor, Sophia G., Fairchild, Timothy J., Learmonth, Yvonne C., Beer, Kelly, Cooper, Ian, Boardman, Glenn, Teo, Shaun Y. M., Shatahmasseb, Behnaz, Zhang, Rui, Hiscock, Krystyne, Coudert, Jerome D., Yeap, Bu B., Needham, Merrilee·2023·PLOS ONE
DOI 10.1371/journal.pone.0283394
Open this paper in CoChat — free account

Abstract

Introduction: Inclusion body myositis (IBM) is the most commonly acquired skeletal muscle disease of older adults involving both autoimmune attack and muscle degeneration. As exercise training can improve outcomes in IBM, this study assessed whether a combination of testosterone supplementation and exercise training would improve muscle strength, physical function and quality of life in men affected by IBM, more than exercise alone. Methods: This pilot study was a single site randomised, double-blind, placebo-controlled, crossover study. Testosterone (exercise and testosterone cream) and placebo (exercise and placebo cream) were each delivered for 12 weeks, with a two-week wash-out between the two periods. The primary outcome measure was improvement in quadriceps isokinetic muscle strength. Secondary outcomes included assessment of isokinetic peak flexion force, walk capacity and patient reported outcomes, and other tests, comparing results between the placebo and testosterone arms. A 12-month Open Label Extension (OLE) was offered using the same outcome measures collected at 6 and 12-months. Results: 14 men completed the trial. There were no significant improvements in quadriceps extension strength or lean body mass, nor any of the secondary outcomes. Improvement in the RAND Short Form 36 patient reported outcome questionnaire ‘emotional wellbeing’ sub-category was reported during the testosterone arm compared to the placebo arm (mean difference [95% CI]: 6.0 points, [95% CI 1.7,10.3]). The OLE demonstrated relative disease stability over the 12-month period but with a higher number of testosterone-related adverse events. Conclusions: Adding testosterone supplementation to exercise training did not significantly improve muscle strength or physical function over a 12-week intervention period, compared to exercise alone. However, the combination improved emotional well-being over this period, and relative stabilisation of disease was found during the 12-month OLE. A longer duration trial involving a larger group of participants is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0283394

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 42

  1. M Needham, 2007, Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches, The Lancet Neurology, 6, 620, 10.1016/S1474-4422(07)70171-0 · DOI · Paper page
  2. MM Dimachkie, 2013, Inclusion body myositis, Current Neurology and Neuroscience reports, 13, 321, 10.1007/s11910-012-0321-4 · DOI
  3. M Needham, 2008, Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis, Journal of Clinical Neuroscience, 15, 1350, 10.1016/j.jocn.2008.01.011 · DOI
  4. JA Tan, 2013, Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30 year epidemiologic study of histology proven cases, International Journal of Rheumatic Diseases, 16, 331, 10.1111/j.1756-185X.2011.01669.x · DOI
  5. CJ Caspersen, 1985, Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research, Public Health Reports, 100, 126
  6. H. Alexanderson, 2012, Exercise in inflammatory myopathies, including inclusion body myositis, Current Rheumatology Reports, 14, 244, 10.1007/s11926-012-0248-4 · DOI
  7. A Gentile, 2019, Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis., Frontiers in Immunology, 10
  8. LG Johnson, 2009, Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis, Journal of Clinical Neuromuscular Disease, 10, 178, 10.1097/CND.0b013e3181a23c86 · DOI · Paper page
  9. LG Johnson, 2007, The effectiveness of an individualized, home-based functional exercise program for patients with sporadic inclusion body myositis, Journal of Clinical Neuromuscular Disease, 8, 187, 10.1097/CND.0b013e3181237291 · DOI
  10. ET Schroeder, 2005, Six-week improvements in muscle mass and strength during androgen therapy in older men., The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60, 1586, 10.1093/gerona/60.12.1586 · DOI
  11. S Bhasin, 1996, The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men, New England Journal of Medicine, 335, 1, 10.1056/NEJM199607043350101 · DOI · Paper page
  12. T Kvorning, 2013, Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low‐normal testosterone levels, Journal of the American Geriatrics Society, 61, 957, 10.1111/jgs.12279 · DOI
  13. L Katznelson, 2006, Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men, European Journal of Endocrinology, 155, 867, 10.1530/eje.1.02291 · DOI
  14. S Rutkove, 2002, A pilot randomized trial of oxandrolone in inclusion body myositis, Neurology, 58, 1081, 10.1212/WNL.58.7.1081 · DOI
  15. S Connor, 2020, A double-blinded randomised controlled trial to establish whether testosterone treatment combined with exercise improves muscle strength and function and quality of life in men affected by inclusion body myositis, Tasman Medical Journal, 3, 69
  16. BB Yeap, 2016, Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations, Medical Journal of Australia, 205, 228, 10.5694/mja16.00448 · DOI · Paper page
  17. LC Chasland, 2021, Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels, American Journal of Physiology-Heart and Circulatory Physiology, 320, H1985, 10.1152/ajpheart.00010.2021 · DOI
  18. S Almosnino, 2012, Reproducibility of isokinetic knee eccentric and concentric strength indices in asymptomatic young adults, Physical Therapy in Sport, 13, 156, 10.1016/j.ptsp.2011.09.002 · DOI
  19. F Ayala, 2012, Absolute reliability of hamstring to quadriceps strength imbalance ratios calculated using peak torque, joint angle-specific torque and joint ROM-specific torque values, International Journal of Sports Medicine, 33, 909, 10.1055/s-0032-1311586 · DOI
  20. JM Drouin, 2004, Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements, European Journal of Applied Physiology, 91, 22, 10.1007/s00421-003-0933-0 · DOI · Paper page
  21. B Bilney, 2003, Concurrent related validity of the GAITRite® walkway system for quantification of the spatial and temporal parameters of gait, Gait & Posture., 17, 68, 10.1016/S0966-6362(02)00053-X · DOI · Paper page
  22. JS Coombes, 2014, ESSA’s Student Manual for Health, Exercise and Sport Assessment-eBook: Elsevier Health Sciences
  23. RW Bohannon, 2015, Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness, Archives of Physical Medicine and Rehabilitation, 96, 472, 10.1016/j.apmr.2014.10.006 · DOI · Paper page
  24. K Berg, 1989, Measuring balance in the elderly: preliminary development of an instrument, Physiotherapy Canada, 41, 304, 10.3138/ptc.41.6.304 · DOI · Paper page
  25. D Kaesler, 2007, A novel balance exercise program for postural stability in older adults: a pilot study, Journal of Bodywork and Movement Therapies, 11, 37, 10.1016/j.jbmt.2006.05.003 · DOI
  26. K. Berg, 1992, Measuring balance in the elderly: Development and validation of an instrument
  27. S Downs, 2013, The Berg Balance Scale has high intra-and inter-rater reliability but absolute reliability varies across the scale: a systematic review, Journal of Physiotherapy, 59, 93, 10.1016/S1836-9553(13)70161-9 · DOI · Paper page
  28. M Pondal, 2008, Normative data and determinants for the timed “up and go” test in a population-based sample of elderly individuals without gait disturbances, Journal of Geriatric Physical Therapy, 31, 57, 10.1519/00139143-200831020-00004 · DOI
  29. D Podsiadlo, 1991, The timed “Up & Go”: a test of basic functional mobility for frail elderly persons, Journal of the American Geriatrics Society, 39, 142, 10.1111/j.1532-5415.1991.tb01616.x · DOI · Paper page
  30. RE Rikli, 1999, Functional fitness normative scores for community-residing older adults, ages 60–94, Journal of Aging and Physical Activity, 7, 162, 10.1123/japa.7.2.162 · DOI · Paper page
  31. PW Duncan, 1990, Functional reach: a new clinical measure of balance, Journal of Gerontology, 45, M192, 10.1093/geronj/45.6.M192 · DOI · Paper page
  32. F Soke, 2021, The functional reach test in people with multiple sclerosis: a reliability and validity study, Physiotherapy Theory and Practice, 1
  33. C Jackson, 2008, Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity, Muscle & Nerve, 37, 473, 10.1002/mus.20958 · DOI
  34. JE Ware, 1992, The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection., Medical Care, 473, 10.1097/00005650-199206000-00002 · DOI · Paper page
  35. RD Hays, 1992, An overview of generic health-related quality of life measures for HIV research., Quality of Life Research, 1, 91, 10.1007/BF00439716 · DOI
  36. RC Team, 2017, R: A language and environment for statistical computing
  37. M. Rose, 2013, 188th ENMC international workshop: inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands., Neuromuscular Disorders, 23, 1044, 10.1016/j.nmd.2013.08.007 · DOI · Paper page
  38. A Cortese, 2013, Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials, Neuromuscular Disorders, 23, 404, 10.1016/j.nmd.2013.02.010 · DOI
  39. M Ahmed, 2016, Targeting protein homeostasis in sporadic inclusion body myositis, Science Translational Medicine, 8, 331, 10.1126/scitranslmed.aad4583 · DOI
  40. MM Fernández-Balsells, 2010, Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis., The Journal of Clinical Endocrinology & Metabolism, 95, 2560, 10.1210/jc.2009-2575 · DOI · Paper page
  41. A Hiscock, 2014, Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision, Physiotherapy, 100, 61, 10.1016/j.physio.2013.06.002 · DOI
  42. LA Schaap, 2005, The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women, Clinical Endocrinology, 63, 152, 10.1111/j.1365-2265.2005.02315.x · DOI · Paper page

Cited by

See all 16

Metadata

Authors
Connor, S. G., Fairchild, T. J., Learmonth, Y. C., Beer, K., Cooper, I., Boardman, G., Teo, S. Y. M., Shatahmasseb, B., Zhang, R., Hiscock, K., Coudert, J. D., Yeap, B. B., & Needham, M.
ORCID
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2023-04-11
Volume
18
Issue
4
Pages
e0283394
ISSN
1932-6203
DOI
10.1371/journal.pone.0283394
Cited by
16
References
1
Language
en
Update notices
correction (2024-06-18)
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.